Simplex Trading’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-9,900
| Closed | -$199K | – | 9806 |
|
|
2026
Q1 | $199K | Buy |
+9,900
| New | +$160K | ﹤0.01% | 4303 |
|
|
2025
Q4 | – | Sell |
-2,000
| Closed | -$24K | – | 9315 |
|
|
2025
Q3 | $24K | Sell |
2,000
-76,700
| -97% | -$1.06M | ﹤0.01% | 7179 |
|
|
2025
Q2 | $889K | Sell |
78,700
-40,400
| -34% | -$494K | ﹤0.01% | 2897 |
|
|
2025
Q1 | $1.37M | Buy |
+119,100
| New | +$1.22M | ﹤0.01% | 2398 |
|
|
2024
Q4 | – | Sell |
-1,500
| Closed | -$17K | – | 9081 |
|
|
2024
Q3 | $17K | Sell |
1,500
-500
| -25% | -$6.29K | ﹤0.01% | 6800 |
|
|
2024
Q2 | $23K | Sell |
2,000
-5,500
| -73% | -$64.2K | ﹤0.01% | 6770 |
|
|
2024
Q1 | $88K | Sell |
7,500
-402,100
| -98% | -$5.36M | ﹤0.01% | 5720 |
|
|
2023
Q4 | $5.02M | Buy |
409,600
+398,800
| +3,693% | +$3.63M | ﹤0.01% | 1548 |
|
|
2023
Q3 | $104K | Buy |
+10,800
| New | +$110K | ﹤0.01% | 5043 |
|
|
2023
Q1 | – | Sell |
-5,600
| Closed | -$37K | – | 9576 |
|
|
2022
Q4 | $37K | Buy |
5,600
+200
| +4% | +$1.07K | ﹤0.01% | 6224 |
|
|
2022
Q3 | $78K | Sell |
5,400
-300
| -5% | -$4.19K | ﹤0.01% | 5857 |
|
|
2022
Q2 | $56K | Buy |
5,700
+4,400
| +338% | +$48.5K | ﹤0.01% | 6337 |
|
|
2022
Q1 | $19K | Buy |
+1,300
| New | +$18.7K | ﹤0.01% | 8299 |
|
|
2021
Q4 | – | Sell |
-500
| Closed | -$12K | – | 10933 |
|
|
2021
Q3 | $12K | Hold |
500
| – | – | ﹤0.01% | 8823 |
|
|
2021
Q2 | $11K | Buy |
500
+476
| +1,983% | +$12.5K | ﹤0.01% | 9036 |
|
|
2021
Q1 | $61K | Sell |
24
-11
| -31% | -$289 | ﹤0.01% | 6368 |
|
|
2020
Q4 | $66K | Buy |
+35
| New | +$600 | ﹤0.01% | 5870 |
|
Other funds holding KALV
Simplex Trading's KALV Position: Q3 2025 in Review
Simplex Trading sold out of KalVista Pharmaceuticals (KALV) in Q3 2025, closing a stake of 3,543 shares — an estimated $49K sold.
Simplex Trading first reported a position in KALV in Q4 2020 and held it in 14 quarters. The position peaked at $297K in Q4 2024. 145 funds tracked by Wall St. Rank hold KALV as of Q3 2025.
- Simplex Trading reported no remaining KalVista Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
- Simplex Trading sold 3,543 KalVista Pharmaceuticals shares in Q3 2025, an estimated $49K.
- Simplex Trading first reported a position in KalVista Pharmaceuticals in Q4 2020 and held it in 14 quarters.
- Simplex Trading's KalVista Pharmaceuticals position peaked at $297K in Q4 2024.
- 145 funds tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q3 2025.
Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.